Blogs about: Angiotech
Featured Blog
Monday Deal Review: May 11, 2009
Check out the latest Patheon-JLL developments, a licensing deal that looks like a subcontracting arrangement, a plan of arrangement M&A that looks like a license, and the rest of the Canadian deal… more →
The Cross-Border Biotech Blog
Monday Deal Review: May 11, 2009
— 5 comments
Jeremy G wrote 2 months ago: Check out the latest Patheon-JLL developments, a licensing deal that looks like a subcontracting arr … more →
Angiotech Expands and Reworks Baxter COSEAL Deal (for real)
Jeremy G wrote 3 months ago: Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) reworked its COSEAL deal with Baxter Intern … more →
Monday Deal Review: March 9, 2009
— 3 comments
Jeremy G wrote 4 months ago: A big dose of Canadian deals and company info from this week M&A/Licensing: Æterna Zentaris Inc … more →
Monday Deal Review: March 2, 2009
— 1 comment
Jeremy G wrote 4 months ago: Canadian deals and company info from this week New Activity: ALERT B&C Corporation(TSXV: ACB) h … more →
Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial
jrowley wrote 1 year ago: Athersys and their cardiac parter, Angiotech, announced today that they got the ok from the FDA to b … more →
Have your say. Start a blog.
See our free features →
An 
Joint
